Private credit performance remains in-line with historical averages and, importantly, credit health remains steady and consistent with previous quarters.

Modest real-world weight loss may significantly reduce a person’s risk for cancer, according to results of a retrospective ...

Gladstone Capital maintains conservative leverage, with a debt-to-equity ratio around 1x, less than the industry average.

Q16W dosing interval; Furthermore, nearly 60% of the participants held the potential to extend the dosing interval to ...

New portal and Snowflake-based data engine allows advisors, enterprises, and asset managers to compare alternatives and move forward with confidence CUMMING, Ga.--(BUSINESS WIRE)--April 01, 2026-- ...

Indirect data suggest oral semaglutide outperforms orforglipron on weight loss and tolerability, with patients also favoring its treatment profile.

A field of seven is set for the 102nd running of the $1.25 million Grade 1 Blue Grass Stakes on the first Saturday of the ...

The 2025 IDSA guidelines provide a comprehensive update on the management of cUTIs and reflect new evidence aiming to improve ...

Based on the Strength of Unprecedented Results from the Positive Phase 1/2 Study in Adults Aged 50 and Older, Vaxcyte Advanced VAX-31 High Dose into Comprehensive Phase 3 Adult Program; Topline Data ...

APEX Part A data demonstrated durable maintenance of response at 52-weeks for every 3- and 6-months dosing, respectively, including:- 75% and 85% ...

There's a quiet financial trap that millions of middle-class households walk right into, usually with a smile on their faces.

Apogee Therapeutics (NASDAQ:APGE) shares rose 15% Monday following positive 52-week data from Part A of its Phase 2 APEX ...